Appili Therapeutics (APLIF) revealed Loss for second quarter of -C$0.99 million
The company's bottom line came in at -C$0.99 million, or -C$0.01 per share. This compares with -C$0.74 million, or -C$0.01 per share, last year.
The company's revenue for the period rose 1900% to C$0.10 million from C$0.005 million last year.
Appili Therapeutics earnings at a glance (GAAP) :
-Earnings: -C$0.99 Mln. vs. -C$0.74 Mln. last year.-EPS: -C$0.01 vs. -C$0.01 last year.-Revenue: C$0.10 Mln vs. C$0.005 Mln last year.
For comments and feedback contact: editorial@rttnews.com
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.